Arzanya and leadXpro AG announce a partnership to explore the potential for combining their specific technology platforms and knowledge to discover macrocyclic ligands binding to membrane protein drug targets.

LimmaTech Biologics AG, a Swiss clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, today announced entry into a definitive agreement to be acquired by Lilly. LimmaTech’s self-adjuvating and multi-antigen vaccine platform addresses common bacterial infections that currently cannot be prevented Lead program focuses on Staphylococcus aureus infection

ten23 health, the human-centric and sustainable strategic CDMO partner of choice for the pharmaceutical industry and biotech start-ups, today announced changes to its leadership team as part of its ongoing commitment to position the company for further long-term growth. These updates reflect a thoughtful alignment of leadership to support the continued expansion of ten23’s capabilities and manuf

Strategic acquisition strengthens InSphero’s presence in the United States and expands advanced imaging and phenotypic analysis capabilities for drug discovery and safety testing

Bionomous releases Sortivo, an automated platform for the gentle screening, sorting and plating of complex biological entities designed to accelerate the adoption of New Approach Methodologies (NAMs).